AM, S., SM, P., RP, G., DA, M., EL, G., B, H., . . . CT, R. (2026). Prior anticoagulation experience and bleeding risk with the factor XI inhibitor abelacimab in AZALEA-TIMI 71. Blood. https://doi.org/10.1182/blood.2026033829
Chicago Style (17th ed.) CitationAM, Small, et al. "Prior Anticoagulation Experience and Bleeding Risk with the Factor XI Inhibitor Abelacimab in AZALEA-TIMI 71." Blood 2026. https://doi.org/10.1182/blood.2026033829.
MLA (9th ed.) CitationAM, Small, et al. "Prior Anticoagulation Experience and Bleeding Risk with the Factor XI Inhibitor Abelacimab in AZALEA-TIMI 71." Blood, 2026, https://doi.org/10.1182/blood.2026033829.
Warning: These citations may not always be 100% accurate.
